Cefixime & Pottasium Clavulanate Tablets – Fexival CV Tablets

FEXIVAL CV Tablets
Composition:- Cefixime Potassium 200 mg.+ Clavulanate 125 mg.

FEXIVAL CV Tablets – The combination of Cefixime & Potassium Clavulanate Tablets provides enhanced efficacy in resistant bacterial infections:
Cefixime – A 3rd-generation cephalosporin that disrupts bacterial cell wall synthesis, leading to bacterial cell death.
Potassium Clavulanate – A β-lactamase inhibitor that neutralizes enzymes that degrade Cefixime, preserving its antibacterial activity.
The result is a potent, synergistic formulation ideal for difficult-to-treat infections, ensuring enhanced therapeutic success.

Key Points of Cefixime & Potassium Clavulanate Tablets – FEXIVAL CV Tablets
• Potent β-Lactamase Inhibition – Clavulanic Acid provides a complementary effect as it extends Cefixime’s spectrum by inhibiting β-lactamase enzymes, making it highly effective against resistant strains.
• Combined Broad-Spectrum Activity – Dual agents with different mechanisms provide synergistic effect and are active against gram-positive, gram-negative, and β-lactamase-producing bacteria for robust infection control.
• Better Clinical Outcomes – Particularly beneficial in recurrent or chronic infections where resistance to standalone cephalosporins may occur.

Can be Prescribed by:
• General Physicians
• Pediatricians
• ENT Specialists
• Healthcare practitioner

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.